Enliven Therapeutics, Inc. (ELVN)

Market Closed

16 Oct, 08:00 PM

NASDAQ (NGS)

$

37. 32

-2.01

-5.1106%

2.93B Market Cap

- P/E Ratio

- Div Yield

1.19M Volume

-2.36 Eps

$ 39.33

Previous Close

Investors:

Add Transaction

Day Range

36.95 39.47

Year Range

14.79 62.32

Want to track ELVN and more in your Portfolio? 🎯

Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Get Started For Free

Enliven Therapeutics, Inc. Investors

Name	Quantity	Cost	Value	Profit ($)	Gain (%)
SAM Smartleaf Asset Management LLC Smartleaf Asset Management LLC	1	$16	$39.28	$23.28	145.5%
BRIANNE SHERGILL Exome Asset Management LLC	100,203	$1.54M	$4M	$2.45M	159.09%
Winfried Buchbauer Erste Asset Management GmbH	25,000	$1.27M	$934,625	-$336,625	-26.48%
Zachary Canonico DIADEMA PARTNERS LP	10,000	$504,670.25	$398,350	-$106,320.25	-21.07%
AMY TEH Arrowpoint Investment Partners (Singapore) Pte. Ltd.	4,499	$228,324	$176,585.3	-$51,738.7	-22.66%
Mark Schafer Police & Firemen's Retirement System of New Jersey	12,635	$316,017.07	$496,302.8	$180,285.73	57.05%
William Staveacre Aster Capital Management (DIFC) Ltd.	28,584	$1.45M	$1.14M	-$315,138.6	-21.68%
Scott Schroeder Longaeva Partners LP	312,560	$14.56M	$11.65M	-$2.91M	-19.99%
Yuen Man Lee Persistent Asset Partners Ltd.	9,433	$402,425.32	$349,021	-$53,404.32	-13.27%
WJ William Jones TEMA ETFs LLC	60,694	$2.58M	$2.26M	-$326,320.73	-12.63%
GFM GF Fund Management Co. Ltd. GF Fund Management Co. Ltd.	1,258	$30,429.52	$46,772.44	$16,342.92	53.71%

1
2

Blog Affiliate Program Dividend Tracker About Terms Privacy Help Contact Us

2026 © Marketlog. All Rights Reserved.